Insider · CIK 0001726010

Dethlefs Sven

Reports to the SEC for 1 company · PETACH TIKVA, L3

sec.gov

Transactions

Companies

Filings

CIK

0001726010

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-07	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−58.1K sh	$9.43	−$547K	165,381
2023-03-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−19.4K sh	$9.93	−$192K	223,447
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−25K sh	—	—	49,905
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+25K sh	—	—	242,802
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+38.5K sh	—	—	217,850
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−13.9K sh	—	—	0
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−38.5K sh	—	—	115,617
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+13.9K sh	—	—	179,312
2023-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+99.6K sh	—	—	99,601
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−42.3K sh	—	—	0
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−17.3K sh	—	—	17,346
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−17.3K sh	$9.89	−$171K	165,381
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+42.3K sh	—	—	207,690
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−42.3K sh	$9.89	−$418K	165,381
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+17.3K sh	—	—	182,727
2023-02-07	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+42.3K sh	—	—	42,309
2022-03-07	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−6,993 sh	$7.37	−$51.5K	165,381
2022-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+25K sh	—	—	172,374
2022-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−25K sh	—	—	74,857
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+154K sh	—	—	154,155
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−13.9K sh	—	—	13,931
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+13.9K sh	—	—	151,326
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−3,904 sh	$7.48	−$29.2K	147,422
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+37.9K sh	—	—	137,396
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−37.9K sh	—	—	0
2022-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−4,862 sh	$8.14	−$39.6K	99,457
2022-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−17.3K sh	—	—	34,692
2022-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+17.3K sh	—	—	104,319
2022-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−13.1K sh	—	—	0
2022-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−4,138 sh	$9.06	−$37.5K	86,973
2022-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+13.1K sh	—	—	91,111
2022-02-08	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+37.9K sh	—	—	37,939
2021-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, North America Commercial	AAward	+99.8K sh	—	—	99,809
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−13.9K sh	—	—	27,861
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+13.9K sh	—	—	83,987.7
2021-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−6,012 sh	$10.57	−$63.5K	77,975.7
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−606 sh	$10.86	−$6,582.736	70,057.7
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,400 sh	—	—	0
2021-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,400 sh	—	—	70,663.7
2021-03-01	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−7,486 sh	$10.83	−$81.1K	69,263.7
2021-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+17.3K sh	—	—	76,749.7
2021-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−17.3K sh	—	—	52,038
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−13.1K sh	—	—	13,135
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−5,695 sh	$12.69	−$72.3K	83,365.7
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDA Award	EVP, North America Commercial	AAward	+55.3K sh	—	—	89,060.7
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, North America Commercial	SSale	−24K sh	$12.69	−$304K	59,403.7
2021-02-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+13.1K sh	—	—	33,773.7
2020-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	−1,179 sh	—	—	0
2020-03-17	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,179 sh	—	—	20,638.7
2020-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, North America Commercial	MExercise/Conversion	+1,399 sh	—	—	19,459.7

Recent filings

Accepted (ET)
Mar 84
Dethlefs Sven0001209191-23-017155
SEC(opens sec.gov)
Mar 74
Dethlefs Sven0001209191-23-016688
SEC(opens sec.gov)
Mar 24
Dethlefs Sven0001209191-23-014436
SEC(opens sec.gov)
Feb 94
Dethlefs Sven0001209191-23-007950
SEC(opens sec.gov)
Mar 84
Dethlefs Sven0001209191-22-017035
SEC(opens sec.gov)

Companies

TEVA PHARMACEUTICAL INDUSTRIES LTDEVP, North America CommercialTEVA

Address

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET

PETACH TIKVA, L3, 4951033